Oncology Central

Chemotherapy-induced thrombocytopenia (CIT) often forces clinicians to delay or reduce cancer treatment. Recently reported data from the Phase III RECITE trial have demonstrated that romiplostim, a thrombopoietin receptor agonist, can help keep gastrointestinal cancer chemotherapy on course when patients are experiencing CIT. In...

Two separate studies have highlighted the impacts that obesity can have on cancer prevalence, revealing that more than half of cancer patients in England had a history of obesity and that excess weight is a key driver behind rising cancer rates in younger adults. Excess weight is the strongest clue to rise in cancer rates in under 50s – but doesn’...

Original story from the University of California - Irvine UC Irvine-led study found that exposure to previously unknown PFAS chemicals was associated with a higher risk of acute lymphoblastic leukemia, the mos...

The ESMO Breast Cancer Congress returns to Berlin, Germany, on May 6–8 2026, bringing together the global breast oncology community to discuss the latest advances in research and clinical practice. With a packed program featuring keynot...

Original story from the AACR Annual Meeting Exposure to wildfire smoke was associated with a significantly increased risk of lung, colorectal, breast...